Artesunate and other artemisinins have been shown to cause hypoglycaemia [21], increased glucose-6-phosphate dehydrogenase activity [22], as well as the conversion of pancreatic α-cells to insulin-secreting β-like cells [23]. Here, INS is linked to Hypoglycemia.